2020
DOI: 10.1016/j.biopha.2020.110525
|View full text |Cite
|
Sign up to set email alerts
|

NF-κB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
13
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(13 citation statements)
references
References 54 publications
0
13
0
Order By: Relevance
“…It is known that chemotherapy with Doxo can induce dose-dependent endothelial dysfunction due to the reduction of vasodilators bioavailability—in particular, nitric oxide—in parallel with increasing the vasoconstrictor agents [ 70 ]. In this process, NF-kB plays an important role as the transcription factor involved in cell proliferation, inflammation and differentiation as a response to oxidative stress [ 71 ]. Generally, free radicals generated by Doxo administration determine the NF-kB translocation into the nucleus and upregulation of different pathways [ 72 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…It is known that chemotherapy with Doxo can induce dose-dependent endothelial dysfunction due to the reduction of vasodilators bioavailability—in particular, nitric oxide—in parallel with increasing the vasoconstrictor agents [ 70 ]. In this process, NF-kB plays an important role as the transcription factor involved in cell proliferation, inflammation and differentiation as a response to oxidative stress [ 71 ]. Generally, free radicals generated by Doxo administration determine the NF-kB translocation into the nucleus and upregulation of different pathways [ 72 ].…”
Section: Resultsmentioning
confidence: 99%
“…Generally, free radicals generated by Doxo administration determine the NF-kB translocation into the nucleus and upregulation of different pathways [ 72 ]. El-Agamy et al [ 73 ] demonstrated that Nrf2 and NF-kB inhibition by Pristimerin reduced the cardiotoxicity triggered by Doxo, while Xu et al [ 71 ] found high expressions of p53 and phosphorylated p53 in Doxo heart rat vessels compared to untreated vessels. These findings confirmed the translocation of p53 into the nucleus after a Doxo treatment and NF-kB pathway activation and, also, its involvement in cardiac fibrosis [ 74 ].…”
Section: Resultsmentioning
confidence: 99%
“…The process of heart remodeling during HF often involves the activation of several ECs and mesenchymal cell transition-related pathways. These pathways include the cell-cell junction reconstruction [38], increased nuclear factor-κB (NF-κB) transcription factor activity [39], activation of the transforming growth factor β (TGF-β)/fibroblast growth factor (FGF) axis coordinating the endothelial cell plasticity and smooth muscle cell migration motility [40], activation of the Smad2/3-Snail signaling pathway to increase EndMT protein expression [41], and the regulation of microRNA (miRNA) expression for a positive or negative mediation of HF progression [42]. Our results showed that hypertensive or ischemic HF significantly reduced the E-cadherin and VE-cadherin expression and increased vimentin and fibronectin expression in the human and rat HF endocardium.…”
Section: Discussionmentioning
confidence: 99%
“…Although the use of this drug has shown excellent results in the treatment of malignant tumors, but its wider use is hindered by its potential cardiotoxicity, which is clinically manifested by cardiomyopathy and congestive heart failure [15,20,25].…”
Section: Discussionmentioning
confidence: 99%